Is the jury out? Class specific differences on coronary outcomes with ACE-inhibitors and ARBs: insight from meta-analysis and The Blood Pressure Lowering Treatment Trialists' CollaborationThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 1, 2005
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Angiotensin II Type 1 Receptor Blockers (MeSH)
- Angiotensin-Converting Enzyme Inhibitors (MeSH)
- Antihypertensive Agents (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Humans (MeSH)
- Hypertension (MeSH)
- Meta-Analysis as Topic (MeSH)
- Myocardial Infarction (MeSH)
- Risk Factors (MeSH)
published in
- European Heart Journal Journal